Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Larger Is The Glioblastoma Multiforme (GBM) Treatment Market Expected To Become By 2029 Compared With Its 2025 Level?
The glioblastoma multiforme (gbm) treatment market size has seen significant development in recent years. It is anticipated to increase from $2.48 billion in 2024 to $2.73 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.8%. This historical expansion is linked to factors such as increased incidence and prevalence, advancements in diagnostic techniques, clinical trials and research funding, collaborations and partnerships, and an improved understanding of tumor biology.
The glioblastoma multiforme (gbm) treatment market size is poised for substantial expansion over the next few years. It is forecast to achieve a valuation of $4.06 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.5%. This growth during the forecast period is propelled by the advent of immunotherapies, advancements in precision medicine, an increased understanding of genetic markers, heightened patient advocacy and awareness, and government initiatives supporting rare diseases. Noteworthy trends for this period encompass the investigation of combination therapies, the incorporation of artificial intelligence into diagnostic and treatment planning processes, an uptick in the adoption of immunotherapeutic strategies, and the evolution of medical tools and equipment.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8803&type=smp
Which Factors And Drivers Are Influencing The Glioblastoma Multiforme (GBM) Treatment Market In 2025?
The glioblastoma multiforme (GBM) treatment market is anticipated to expand due to the rising occurrence of brain disorders. These disorders involve anomalous operation of the brain, along with nerves present across the human body and spinal cord. Factors like an aging population, weakened immune systems, increased diagnosis, ionizing radiation, and air pollution contribute to the growing incidence of brain disorders, including glioblastoma multiforme (GBM), thereby necessitating their treatment for enhanced well-being. A pertinent example is the finding from a 2022 report by the American Cancer Society, a US-based voluntary health organization focused on cancer eradication, which indicated approximately 25,050 malignant brain or spinal cord cancer diagnoses in the US. Consequently, the rising prevalence of brain disorders acts as a significant catalyst for the expansion of the glioblastoma multiforme (GBM) treatment market.
What Are The Segment Types Shaping The Glioblastoma Multiforme (GBM) Treatment Market?
The glioblastoma multiforme (gbm) treatmentmarket covered in this report is segmented –
1) By Treatment: Surgery; Radiation Therapy; Chemotherapy; Targeted Therapy; Tumor Treating Field (TTF) Therapy; Immunotherapy
2) By Drug Class: Temozolomide; Bevacizumab; Lomustine; Carmustine Wafers; Other Drug Classes
3) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations
4) By End-Use: Hospitals; Clinics; Ambulatory Surgical Centers
Subsegments:
1) By Surgery: Tumor Resection; Biopsy Procedures
2) By Radiation Therapy: External Beam Radiation Therapy (EBRT); Stereotactic Radiation Therapy
3) By Chemotherapy: Standard Chemotherapy; Combination Chemotherapy Regimens
4) By Targeted Therapy: EGFR Inhibitors; Other Targeted Agents
5) By Tumor Treating Field (TTF) Therapy: Device-Based TTF Treatment
6) By Immunotherapy: Checkpoint Inhibitors; Vaccine-Based Therapies
Which Key Trends Are Expected To Influence The Glioblastoma Multiforme (GBM) Treatment Market In The Coming Years?
Leading companies operating in the market are concentrating on developing innovative wearable and portable devices to maintain their position within the industry. These advancements aim to offer users enhanced functionality, convenience, and comfort, addressing the rising demand for accessible and efficient healthcare solutions. For instance, in 2023, Novocure, a Jersey-based oncology company, launched Optune Gio, an FDA-approved wearable and portable treatment system for patients newly diagnosed with glioblastoma (GBM). This device employs Tumor Treating Fields (TTFields), which are alternating electric fields that disrupt cancer cell division, potentially extending patient survival. Weighing only 2.7 pounds, Optune Gio is designed for comfort, allowing patients to wear it during daily activities.
Which Leading Players Are Enhancing Their Glioblastoma Multiforme (GBM) Treatment Market Presence Worldwide?
Major companies operating in the glioblastoma multiforme (GBM) treatment market include Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, AstraZeneca PLC, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Jazz Pharmaceuticals Inc., Sumitomo Dainippon Pharma Oncology Inc., Varian Medical Systems Inc., Amneal Pharmaceuticals Inc., Elekta AB, ANI Pharmaceuticals Inc., Accord Healthcare Limited, The Eckert & Ziegler Group, Loxo Oncology Inc., Karyopharm Therapeutics Inc., Celon Laboratories Pvt. Ltd., EnGeneIC Ltd., Zydus Pharmaceuticals Inc., Genenta Science S.r.l., Cantex Pharmaceuticals Inc., Vascular Biogenics Ltd., Seelos Therapeutics Inc, Angiochem Inc., Diffusion Pharmaceuticals Inc.
Download The Full Report For Exclusive Market Findings:
How Does The Glioblastoma Multiforme (GBM) Treatment Market Perform Across Key Geographic Regions?
North America was the largest region in the glioblastoma multiforme (GBM) treatment market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glioblastoma multiforme (gbm) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Glioblastoma Multiforme (GBM) Treatment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=8803&type=smp
Browse Through More Reports Similar to the Global Glioblastoma Multiforme (GBM) Treatment Market 2025, By The Business Research Company
Neurology Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report
Neurodegenerative Disorder Therapeutic Global Market Report 2025
Neurophysiology Devices And Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model